Investigating novel treatment options in systemic sclerosis

EULAR, The European Alliance of Associations for Rheumatology, updated its recommendations for systemic sclerosis (SSc) in 2023. Notably, four new therapies were added that had not been included in 2017—highlighting how fast the field is changing. New, strong evidence is now available to help better manage patients with this life-threatening condition, but gaps remain.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup